BEUDAMED
    FDA Adverse Event Other Summary report: N

    SYNVISC

    MDR report key: 755933 · Received August 22, 2006

    Report

    Report Number
    MW1040117
    Event Type
    Other
    Date Received
    August 22, 2006
    Date of Event
    August 4, 2006
    Report Date
    August 10, 2006
    Manufacturer
    *
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    CA, US
    Reporter Occupation
    PHYSICIAN

    Narratives

    Description of Event or Problem · 1

    WITHIN DAY AFTER 1ST AND 2ND SYNVISC INJECTIONS THIS RETIRED PHYSICIAN'S BLOOD SUGAR ROSE TO 427 AFTER 1ST SYNVISC AND 446 AFTER 2ND SYNVISC INJECTION. PT IS KNOWN TYPE II DIABETIC AFTER 2ND SYNVISC, K +ALSO DECREASED TO 2.4. PATIENT REFUSED 3RD SYNVISC.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 SYNVISC * MOZ * 50605 *
    2 SYNVISC * MOZ * * 50605

    Patients

    Seq Age Sex Outcome Treatment
    1 84 YR Other